TOMSK, RUSSIA / RankWire.AI / – Russian scientists have evaluated a new bioactive surface layer aimed at enhancing the interaction between titanium orthopedic implants and bone tissue. The coating is based on calcium phosphate derived from hydroxyapatite and incorporates nitrogen compounds linked to nitric oxide synthesis. Laboratory experiments demonstrated a notably increased survival rate of human mesenchymal stem cells on the coated surfaces compared to uncoated titanium. The researchers analyzed the coating’s structure, chemistry, mechanical characteristics, and biological effects. Their peer-reviewed results were published in Applied Surface Science in 2026.
At Tomsk Polytechnic University, scientists produced the experimental coatings using reactive magnetron sputtering of a hydroxyapatite target within a vacuum chamber. They adjusted the nitrogen and argon gas ratios during the process to observe how each mixture influenced the resulting surface. The study tested five different conditions, from pure nitrogen to pure argon. They measured parameters such as coating thickness, surface morphology, hardness, wettability, and chemical composition. Additionally, laboratory tests assessed how living human cells responded to the modified titanium surface.
The results indicated that the argon proportion influenced several physical properties of the coatings. Surfaces formed in pure argon were denser and harder than those created with pure nitrogen. Coating thickness increased as the argon concentration rose. Chemical analysis revealed nitrogen-carbon and nitrogen-oxygen bonds present on the modified surfaces. The team then compared the behavior of human mesenchymal stem cells grown on coated titanium versus uncoated titanium. The biological assessments focused on cell viability and markers associated with osteogenic differentiation.
Enhanced Cell Survival Observed in Coating Tests
The experiments showed that cell survival was significantly higher on coated surfaces than on uncoated titanium, according to the published results. After seven days, coatings with increased nitrogen content also suppressed activity in certain genes linked to early bone-cell differentiation. Despite this, the cells maintained their ability to form bone tissue. These findings were obtained under controlled laboratory conditions using human mesenchymal stem cells. The study did not involve testing the coating in patients or assessing its clinical performance in implants.
The biomedical evaluation was carried out by Immanuel Kant Baltic Federal University and Siberian State Medical University, with participation from Saint Petersburg State University. The project was funded through Russia’s national science program. The researchers aimed to identify gas mixtures capable of producing coatings with optimal physical, chemical, and biological properties. Hydroxyapatite has long been used in implant coatings because its calcium phosphate composition resembles the mineral found in human bone.
Current Study is Limited to Laboratory Testing
The research team plans additional testing beyond the initial seven-day cell experiments. Future studies will evaluate stem cell behavior over periods ranging from 10 to 28 days, along with analyzing how quickly the coatings dissolve and measuring nitric oxide release into surrounding tissue in vivo. These follow-up investigations are not included in the current publication. The present research focuses on coated titanium substrates, their material properties, and in vitro cellular responses, rather than clinical outcomes in orthopedic patients.
The data obtained provides comprehensive insight into how varying nitrogen and argon ratios influence calcium phosphate coatings on titanium surfaces. Differences in coating thickness, density, hardness, chemical bonds, and cellular responses across the tested gas mixtures are documented. The study also confirms that coated samples support higher stem-cell survival compared to uncoated titanium under laboratory conditions. Nonetheless, this research remains preclinical, and the experiments do not establish safety or efficacy in humans. Further biological testing will be necessary to evaluate additional properties not addressed in this study.